MedPath

Saphenous Vein as Y-composite Versus Aortocoronary Conduit for CABG

Not Applicable
Recruiting
Conditions
Coronary Artery Disease
Interventions
Procedure: Y-composite grafting
Procedure: Aortocoronary grafting
Registration Number
NCT05704296
Lead Sponsor
Ho Young Hwang
Brief Summary

Left internal thoracic artery (LITA) has been acknowledged as the first graft of choice for coronary artery bypass grafting (CABG). However, it is still not conclusive which one is the best second graft of choice among right internal thoracic artery, radial artery, right gastroepiploic artery, saphenous vein, and etc., as well as its configuration for CABG.

In our institution, saphenous vein has been primarily used for the second graft and we have harvested it with 'No touch technique'. We have been demonstrated the excellent long-term patency of this 'No touch saphenous vein' in many studies. However, it is still unknown which configuration is the better strategy for the saphenous vein as a Y-composite graft based on the left internal thoracic artery versus an aortocoronary conduit. Thus, we aimed to evaluate morphologic change of saphenous vein graft by 1-year intravascular ultrasound (IVUS) study and angiographic patency results between Y-composite graft and aortocoronary conduit.

Detailed Description

The enrolled patient underwent routine sternotomy, and left internal thoracic artery (LITA) and saphenous vein (SV) are harvested. After harvest, the patient is randomized to Y-composite group or aortocoronary group.

For Y-composite group, SV is anastomosed to LITA as Y-composite fashion. Then, LITA is anastomosed to left anterior descending artery. SV is anastomosed to the rest of the target vessels with sequential anastomosis technique (e.g. diagonal branch, obtuse marginal branch, posterolateral branch and posterior descending artery).

For aortocoronary group, LITA is anastomosed to left anterior descending artery. Then, SV is anastomosed to ascending aorta using proximal anastomosis assist device without clamping the aorta. SV is anastomosed to the rest of the target vessels with sequential anastomosis technique (e.g. diagonal branch, obtuse marginal branch, posterolateral branch and posteriori descending artery).

At 1-year follow-up, coronary angiography is performed to evaluate the patency of the saphenous vein graft. Clinical outcomes are also evaluated.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
290
Inclusion Criteria
  • A patient who is going to receive coronary artery bypass grafting
  • Older than 19 years
  • Coronary artery bypass grafting is going to be performed with left internal thoracic artery and saphenous vein graft
Exclusion Criteria
  • Other concomitant procedures (e.g. valve or aorta surgery) is planned
  • Patients with severe comorbidities which limit the life expectancy of them below 1 year (e.g. terminal cancer)
  • Patients whose left internal thoracic artery or saphenous vein is not available due to the low quality, severe injury, or absence of the graft
  • Patients whose ascending aorta is not suitable to aortocoronary anastomosis (e.g. ascending aorta aneurysm, porcelain aorta)
  • Emergency operation
  • Patients who have connective tissue disease
  • Reoperative coronary artery bypass grafting

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Y-composite graftingY-composite graftingThe saphenous vein is anastomosed to the middle portion of the left internal thoracic artery as Y-composite fashion. Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery. Other native coronary arterial targets are bypassed with saphenous vein graft.
Aortocoronary graftingAortocoronary graftingThe saphenous vein is anastomosed to the ascending aorta as aortocoronary fashion. Then, left anterior descending artery, if targeted, is bypassed with left internal thoracic artery. Other native coronary arterial targets are bypassed with saphenous vein graft.
Primary Outcome Measures
NameTimeMethod
Graft patencyat postoperative 1 year

Graft patency measured by coronary angiography

Secondary Outcome Measures
NameTimeMethod
Cardiac deathat postoperative 1 year

Any death related to cardiac events, including sudden death during follow-up

Target vessel revascularizationat postoperative 1 year

Intervention performed for the previously bypassed target vessel during follow-up

Reinterventionat postoperative 1 year

Any coronary intervention performed during follow-up due to the coronary artery disease

Major Adverse Cardiac Events (MACEs)at postoperative 1 year

acute myocardial infarction, coronary reintervention, and cardiac death including sudden death during follow-up

All-cause mortalityat postoperative 1 year

all deaths from any cause

Trial Locations

Locations (1)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath